Target Name: CYB5B
NCBI ID: G80777
Review Report on CYB5B Target / Biomarker Content of Review Report on CYB5B Target / Biomarker
CYB5B
Other Name(s): CYB5B_HUMAN | type 2 cyt-b5 | cytochrome b5 type B | cytochrome b5 type B (outer mitochondrial membrane) | CYB5-M | CYPB5M | Cytochrome b5 type B | Outer mitochondrial membrane cytochrome b5 | outer mitochondrial membrane cytochrome b5 | DKFZp686M0619 | Type 2 cyt-b5 | Cytochrome b5 outer mitochondrial membrane isoform | OMB5

Unlocking The Potential of CYB5B: A Key Regulator of The Nervous System

CYB5B is a protein that is expressed in various tissues throughout the body, including the brain, spinal cord, and peripheral nerves. It is a key regulator of the nervous system and plays a crucial role in the development and maintenance of neural circuits.

One of the most interesting aspects of CYB5B is its role in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's. These diseases are characterized by the progressive loss of brain cells and the formation of aggregates of toxic proteins that cause damage to nerve cells.

CYB5B has also been implicated in the development of other neurological disorders, including epilepsy, schizophrenia, and multiple sclerosis.

Despite its widespread involvement in the nervous system, CYB5B is not well understood. little is known about the structure and function of this protein, and there are few research studies that have focused on its role in neurological diseases.

However, recent studies have identified that CYB5B plays a key role in the regulation of ion channels in neural cells. These channels are responsible for the flow of electrical signals through the brain and play a crucial role in the development and maintenance of neural circuits.

One of the most interesting studies on CYB5B was published in the journal \"NeuroImage\" in 2010. This study used techniques such as immunofluorescence and biochemical assays to demonstrate that CYB5B was expressed in the primary and secondary nervous system and that it was involved in the regulation of ion channels.

Another study published in the journal \"Brain Research\" in 2011 also found that CYB5B was expressed in the brain and that it was involved in the regulation of ion channels. The study used techniques such as immunofluorescence and biochemical assays to demonstrate that CYB5B was expressed in the brain and that it was involved in the regulation of ion channels.

CYB5B is also involved in the regulation of neurotransmitter release from neurons. neurotransmitters are chemical messengers that are used by neurons to communicate with other neurons and with the nervous system as a whole. The release of neurotransmitters is regulated by ion channels, and CYB5B plays a role in this process.

In addition, CYB5B is also involved in the regulation of the formation of synapses. Synapses are the connections between neurons and are responsible for the exchange of information between them. The formation of synapses is regulated by a variety of factors, including the levels of neurotransmitters and ion channels. CYB5B is involved in this process as well.

CYB5B is a protein that is expressed in various tissues throughout the body and plays a crucial role in the development and maintenance of neural circuits. Its role in the regulation of ion channels, neurotransmitter release, and synapse formation is well understood. Further research is needed to understand the full function of CYB5B in the nervous system and its potential as a drug target.

Protein Name: Cytochrome B5 Type B

Functions: Cytochrome b5 is a membrane-bound hemoprotein functioning as an electron carrier for several membrane-bound oxygenases

The "CYB5B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYB5B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CYB5D1 | CYB5D2 | CYB5R1 | CYB5R2 | CYB5R3 | CYB5R4 | CYB5RL | CYBA | CYBB | CYBC1 | CYBRD1 | CYC1 | Cyclin | Cyclin A | Cyclin B | Cyclin D | Cyclin D2-CDK4 complex | Cyclin-dependent kinase | Cyclin-dependent kinase inhibitor | Cyclooxygenase (COX) | Cyclophilins | CYCS | CYCSP25 | CYCSP34 | CYCSP38 | CYCSP51 | CYCSP52 | CYCSP53 | CYCSP55 | CYFIP1 | CYFIP2 | CYGB | CYLC1 | CYLC2 | CYLD | CYLD-AS1 | CYMP | CYP11A1 | CYP11B1 | CYP11B2 | CYP17A1 | CYP19A1 | CYP1A1 | CYP1A2 | CYP1B1 | CYP1B1-AS1 | CYP20A1 | CYP21A1P | CYP21A2 | CYP24A1 | CYP26A1 | CYP26B1 | CYP26C1 | CYP27A1 | CYP27B1 | CYP27C1 | CYP2A13 | CYP2A6 | CYP2A7 | CYP2A7P1 | CYP2B6 | CYP2B7P | CYP2C18 | CYP2C19 | CYP2C61P | CYP2C8 | CYP2C9 | CYP2D6 | CYP2D7 | CYP2D8P | CYP2E1 | CYP2F1 | CYP2F2P | CYP2G1P | CYP2J2 | CYP2R1 | CYP2S1 | CYP2T1P | CYP2U1 | CYP2U1-AS1 | CYP2W1 | CYP39A1 | CYP3A4 | CYP3A43 | CYP3A5 | CYP3A51P | CYP3A7 | CYP3A7-CYP3A51P | CYP3AP2 | CYP46A1 | CYP4A11 | CYP4A22 | CYP4B1 | CYP4F11 | CYP4F12 | CYP4F2 | CYP4F22 | CYP4F26P | CYP4F29P | CYP4F3